Valthos is an applied biological intelligence company developing AI systems to identify biological threats and design medical countermeasures in real time. Founded in 2024, the company has raised $30 million in early-stage funding and operates at the intersection of artificial intelligence, biotechnology, computational biology, and bioinformatics. Its founding team includes individuals with backgrounds at Palantir, DeepMind, MIT's Broad Institute, and the Arc Institute.
The company's Biodefense AI Platform draws on biological data from government and commercial sources - including air and wastewater monitoring - to detect emerging threats, assess risks, analyze biological sequences, and adapt existing medicines in response to pathogens. The platform's stated goal is to reduce response time from months to hours.
Valthos describes its mission as safeguarding humanity against biological threats and states it is assembling talent to work on what it characterizes as one of the most impactful missions in the world. The company operates in the biodefense, biotechnology, pharmaceuticals, and public health verticals.
